Cargando…

Management of Parkinson’s disease challenged by co-morbid drug abuse

INTRODUCTION: Parkinson’s disease (PD) is a neurologic degenerative condition with complex neuropsychiatric manifestations which can be challenging to manage and greatly impact quality of life and prognosis. OBJECTIVES: The description of this case aims to highlight the complex interaction between P...

Descripción completa

Detalles Bibliográficos
Autores principales: Simas, J., Delgado, A., Guedes, R., Silveira, C., Soares, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566004/
http://dx.doi.org/10.1192/j.eurpsy.2022.1188
_version_ 1784809031267778560
author Simas, J.
Delgado, A.
Guedes, R.
Silveira, C.
Soares, C.
author_facet Simas, J.
Delgado, A.
Guedes, R.
Silveira, C.
Soares, C.
author_sort Simas, J.
collection PubMed
description INTRODUCTION: Parkinson’s disease (PD) is a neurologic degenerative condition with complex neuropsychiatric manifestations which can be challenging to manage and greatly impact quality of life and prognosis. OBJECTIVES: The description of this case aims to highlight the complex interaction between PD, drug-abuse and impulse control disorder (ICD). METHODS: Clinical information was obtained through patient interviewing and medical records consulting. A literature review on the topic was conducted. RESULTS: We report the case of a 52-years-old male with PD diagnosed at the age of 45, presenting with rigidity of right limbs and freezing of gait. He had a history of multiple substance-abuse: hashish, heroin and cocaine, with cessation of all substances by the age of 40. The patient responded well to antiparkinsonian medication initially, but needed frequent adjustments and developed ICD secondary to dopamine agonists, presenting pathological gambling and hypersexuality. At 47 he restarted using cocaine stating that it diminished the motor symptoms. Motor symptoms worsened and became partially responsive to medication. Pharmacologic options were limited due to ICD. He developed dopamine dysregulation syndrome, abusing dopaminergic drugs and requesting multiple prescriptions. Deep brain stimulation surgery was proposed, but the patient was deemed unfit for the procedure after two separate psychiatric evaluations, mainly because of behaviour and social problems in relation to sustained cocaine abuse and personality disorder. Attempts to stop drug abuse were unsuccessful despite several interventions by addiction psychiatry. CONCLUSIONS: Co-occurrence of PD, substance-abuse and personality disorder poses as a therapeutic challenge conditioned by pharmacological iatrogenesis and behavioural disturbances, requiring a multidisciplinary and individualized approach. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9566004
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95660042022-10-17 Management of Parkinson’s disease challenged by co-morbid drug abuse Simas, J. Delgado, A. Guedes, R. Silveira, C. Soares, C. Eur Psychiatry Abstract INTRODUCTION: Parkinson’s disease (PD) is a neurologic degenerative condition with complex neuropsychiatric manifestations which can be challenging to manage and greatly impact quality of life and prognosis. OBJECTIVES: The description of this case aims to highlight the complex interaction between PD, drug-abuse and impulse control disorder (ICD). METHODS: Clinical information was obtained through patient interviewing and medical records consulting. A literature review on the topic was conducted. RESULTS: We report the case of a 52-years-old male with PD diagnosed at the age of 45, presenting with rigidity of right limbs and freezing of gait. He had a history of multiple substance-abuse: hashish, heroin and cocaine, with cessation of all substances by the age of 40. The patient responded well to antiparkinsonian medication initially, but needed frequent adjustments and developed ICD secondary to dopamine agonists, presenting pathological gambling and hypersexuality. At 47 he restarted using cocaine stating that it diminished the motor symptoms. Motor symptoms worsened and became partially responsive to medication. Pharmacologic options were limited due to ICD. He developed dopamine dysregulation syndrome, abusing dopaminergic drugs and requesting multiple prescriptions. Deep brain stimulation surgery was proposed, but the patient was deemed unfit for the procedure after two separate psychiatric evaluations, mainly because of behaviour and social problems in relation to sustained cocaine abuse and personality disorder. Attempts to stop drug abuse were unsuccessful despite several interventions by addiction psychiatry. CONCLUSIONS: Co-occurrence of PD, substance-abuse and personality disorder poses as a therapeutic challenge conditioned by pharmacological iatrogenesis and behavioural disturbances, requiring a multidisciplinary and individualized approach. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9566004/ http://dx.doi.org/10.1192/j.eurpsy.2022.1188 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Simas, J.
Delgado, A.
Guedes, R.
Silveira, C.
Soares, C.
Management of Parkinson’s disease challenged by co-morbid drug abuse
title Management of Parkinson’s disease challenged by co-morbid drug abuse
title_full Management of Parkinson’s disease challenged by co-morbid drug abuse
title_fullStr Management of Parkinson’s disease challenged by co-morbid drug abuse
title_full_unstemmed Management of Parkinson’s disease challenged by co-morbid drug abuse
title_short Management of Parkinson’s disease challenged by co-morbid drug abuse
title_sort management of parkinson’s disease challenged by co-morbid drug abuse
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566004/
http://dx.doi.org/10.1192/j.eurpsy.2022.1188
work_keys_str_mv AT simasj managementofparkinsonsdiseasechallengedbycomorbiddrugabuse
AT delgadoa managementofparkinsonsdiseasechallengedbycomorbiddrugabuse
AT guedesr managementofparkinsonsdiseasechallengedbycomorbiddrugabuse
AT silveirac managementofparkinsonsdiseasechallengedbycomorbiddrugabuse
AT soaresc managementofparkinsonsdiseasechallengedbycomorbiddrugabuse